Prof. Dr. Abhay H Pande, National Institute of Pharmaceutical Education and Research (NIPER), S.A.S. Nagar, Punjab, India
Abhay H Pande is a distinguished professor at the National Institute of Pharmaceutical Education and Research (NIPER), S.A.S. Nagar, Punjab. He leads the Protein Biopharmaceutical Lab, where his work focuses on the development of innovative biopharmaceuticals targeting inflammatory disorders, cancer, and bioterrorism defense. Notable advancements include the development of bispecific antibodies and prophylactic biologics like LBUPON™. With 18 patents and over 80 scientific publications, Pande’s research has gained global recognition. He is also deeply committed to bridging academia and industry, playing a key role in incubation initiatives such as CPIE and BioNEST. His passion for teaching is reflected in his contributions to curriculum development and mentoring numerous Ph.D. and Master’s students. Pande is recognized for his leadership in pharmaceutical innovation, sustainability, and promoting biotechnology’s role in global health solutions.
Professional Profile
scopus
google scholar
Summary of Suitability for the Award
Dr. Abhay H. Pande is highly suitable for the Research for Best Researcher Award based on his extensive and impactful contributions to the field of biopharmaceuticals. As a professor at the National Institute of Pharmaceutical Education and Research (NIPER), his innovative research focuses on developing novel biologics for critical healthcare challenges, including cancer, inflammatory diseases, and bioterrorism defense. His work has led to the development of pioneering biologics such as BiSpekDAb™, ApoEFrag™, and LBUPON™, which are in advanced pre-clinical stages, showcasing his expertise in translating scientific discoveries into real-world solutions.
Education
Abhay H Pande completed his education in biopharmaceutical sciences, with a strong emphasis on biotechnology and pharmaceutical development. His academic journey equipped him with the knowledge and skills to develop biopharmaceutical solutions to address global healthcare challenges. Over the years, he has designed comprehensive curricula for M.Tech programs in Biopharmaceuticals and Medical Devices, reflecting his expertise in interdisciplinary fields like biochemistry, biotechnology, immunology, and cell biology. Pande’s academic foundation and continuous learning have fueled his innovative work in developing therapeutics for cancer, inflammatory disorders, and bioterrorism defense. His teaching and curriculum design efforts further demonstrate his dedication to education and the dissemination of biopharmaceutical knowledge.
Experience
Abhay H Pande has over two decades of experience in the pharmaceutical and biotechnology fields, currently serving as a professor at NIPER. He has led numerous research projects aimed at developing innovative biologics, such as bispecific antibodies and anticancer biologics. Pande has also held leadership roles as the chairman of the CPIE-Incubation Center and project coordinator for BioNEST, where he fosters collaboration between academia and industry. His experience includes teaching courses in Biochemistry, Biotechnology, Immunology, and Cell Biology, as well as supervising the research of 9 Ph.D. scholars and 138 master’s theses. His contributions span across research, innovation, and academic leadership.
Awards and Honors
Abhay H Pande has been recognized for his groundbreaking work in biopharmaceuticals through numerous awards and honors. He has secured 18 patents for his innovative biologics and therapeutic developments. His research contributions have been honored at prestigious national forums, reflecting the widespread recognition of his work. Additionally, Pande has been invited to deliver lectures globally on biotechnology’s role in sustainability and healthcare. As a leader in pharmaceutical education, he has received accolades for his role in fostering academia-industry collaboration, mentoring students, and advancing innovative research in biotechnology.
Research Focus
Abhay H Pande’s research focuses on the development of innovative biopharmaceutical solutions to address global healthcare challenges. His work primarily targets inflammatory disorders, cancer, and bioterrorism defense. Key innovations include the development of bispecific antibodies (BiSpekDAb™) and prophylactic biologics (LBUPON™). Pande’s research also explores enzyme-based therapies for cardiovascular disorders, cancer treatment, and nerve agent poisoning. He collaborates with national and international research institutions, focusing on creating sustainable, scalable solutions for biopharmaceutical challenges. His research not only addresses urgent healthcare needs but also aims to make significant contributions to global sustainability through biotechnology.
Publication Top Notes
-
Title: Membrane fluidity is a key modulator of membrane binding, insertion, and activity of 5-lipoxygenase
Citations: 141
-
Title: Conformational instability of the cholera toxin A1 polypeptide
Citations: 92
-
Title: Studies on a Doubleheaded Protease Inhibitor from Phaseolus mungo
Citations: 65
-
Title: Modulation of human 5-lipoxygenase activity by membrane lipids
Citations: 62
-
Title: The N-terminal α-helix of pancreatic phospholipase A2 determines productive-mode orientation of the enzyme at the membrane surface
Citations: 60